48 U.S. lawmakers have disclosed 112 Abbott Laboratories trades under the STOCK Act — 64 buys and 47 sells between 2012 and 2026. Congress has been net buyers of ABT, and their disclosed buys are up 5.9% versus the latest close.
*Notional-weighted price return on lawmakers' disclosed buys of ABT, marked to the latest close — per-share (share counts aren't disclosed).
2 members disclosed a ABT purchase in the last 90 days (newest first).
Lawmakers ranked by notional-weighted return on their disclosed ABT buys (last ~3y), marked to the latest close.
| Date | Member | Type | Amount | Est. price | Latest close | Return |
|---|---|---|---|---|---|---|
| 2020-09-23 | Dean Phillips | BUY | $1K–$15K | $102.73 | $111.27 2026-08-13 | +8.3% |
| 2020-08-28 | David B. McKinley | SELL | $1K–$15K | $110.79 | $111.27 2026-08-13 | -0.4% exit |
| 2020-07-28 | Carol Devine Miller | BUY | $15K–$50K | $99.86 | $111.27 2026-08-13 | +11.4% |
| 2020-04-07 | Kelly Loeffler | BUY | $1K–$15K | $81.93 | $111.27 2026-08-13 | +35.8% |
| 2020-03-03 | Shelley M Capito | BUY | $1K–$15K | $77.99 | $111.27 2026-08-13 | +42.7% |
| 2019-12-31 | Joe Courtney | BUY | $1K–$15K | $86.86 | $111.27 2026-08-13 | +28.1% |
| 2019-07-09 | Elizabeth Fletcher | SELL | $1K–$15K | $85.27 | $111.27 2026-08-13 | -30.5% exit |
| 2019-06-20 | Dean Phillips | BUY | $1K–$15K | $84.94 | $111.27 2026-08-13 | +31.0% |
| 2019-04-09 | Tina Smith | SELL | $250K–$500K | $78.67 | $111.27 2026-08-13 | -41.4% exit |
| 2019-03-15 | Josh Gottheimer | BUY | $1K–$15K | $79.86 | $111.27 2026-08-13 | +39.3% |
| 2019-02-27 | Josh Gottheimer | BUY | $1K–$15K | $77.23 | $111.27 2026-08-13 | +44.1% |
| 2019-02-18 | Kenny Marchant | BUY | $1K–$15K | $75.25 | $111.27 2026-08-13 | +47.9% |
| 2018-11-05 | Thomas J. Rooney | BUY | $15K–$50K | $70.39 | $111.27 2026-08-13 | +58.1% |
| 2018-05-02 | Pete Sessions | BUY | $1K–$15K | $57.85 | $111.27 2026-08-13 | +92.3% |
| 2018-04-24 | Shelley M Capito | BUY | $1K–$15K | $58.31 | $111.27 2026-08-13 | +90.8% |
| 2018-04-24 | Shelley M Capito | BUY | $1K–$15K | $58.31 | $111.27 2026-08-13 | +90.8% |
| 2018-04-05 | Shelley M Capito | BUY | $1K–$15K | $59.86 | $111.27 2026-08-13 | +85.9% |
| 2018-04-05 | Shelley M Capito | BUY | $1K–$15K | $59.86 | $111.27 2026-08-13 | +85.9% |
| 2017-12-08 | Kenny Marchant | BUY | $15K–$50K | $54.64 | $111.27 2026-08-13 | +103.6% |
| 2017-11-07 | Kenneth R. Buck | SELL | $1K–$15K | $55.16 | $111.27 2026-08-13 | -101.7% exit |
| 2017-10-24 | William Cassidy | SELL | $1K–$15K | $55.38 | $111.27 2026-08-13 | +32.4% rt |
| 2017-10-24 | James B. Renacci | BUY | $1K–$15K | $55.38 | $111.27 2026-08-13 | +100.9% |
| 2017-10-24 | William Cassidy | SELL | $1K–$15K | $55.38 | $111.27 2026-08-13 | +32.4% rt |
| 2017-10-23 | James B. Renacci | SELL | $1K–$15K | $56.08 | $111.27 2026-08-13 | +32.9% rt |
| 2017-10-18 | Tammy Duckworth | SELL | $1K–$15K | $55.77 | $111.27 2026-08-13 | -99.5% exit |
| 2017-10-11 | Lois Frankel | SELL | $1K–$15K | $54.44 | $111.27 2026-08-13 | -104.4% exit |
| 2017-10-04 | Lois Frankel | SELL | $1K–$15K | $54.34 | $111.27 2026-08-13 | -104.8% exit |
| 2017-09-12 | George Holding | BUY | $1K–$15K | $52.25 | $111.27 2026-08-13 | +113.0% |
| 2017-07-06 | Lois Frankel | SELL | $1K–$15K | $47.94 | $111.27 2026-08-13 | -132.1% exit |
| 2017-04-19 | K. Michael Conaway | SELL | $15K–$50K | $43.59 | $111.27 2026-08-13 | -155.3% exit |
| 2017-02-23 | Sheldon Whitehouse | SELL | $1K–$15K | $45.40 | $111.27 2026-08-13 | +14.0% rt |
| 2017-01-26 | James B. Renacci | BUY | $1K–$15K | $40.96 | $111.27 2026-08-13 | +171.7% |
| 2017-01-26 | Peter Welch | BUY | $1K–$15K | $40.96 | $111.27 2026-08-13 | +171.7% |
| 2016-12-20 | James B. Renacci | SELL | $1K–$15K | $38.19 | $111.27 2026-08-13 | +20.3% rt |
| 2016-12-20 | James B. Renacci | BUY | $1K–$15K | $38.19 | $111.27 2026-08-13 | +191.4% |
| 2016-11-15 | Sheldon Whitehouse | BUY | $1K–$15K | $39.81 | $111.27 2026-08-13 | +179.5% |
| 2016-11-10 | Virginia Foxx | SELL | $1K–$15K | $40.61 | $111.27 2026-08-13 | +1.4% rt |
| 2016-06-01 | Debbie Dingell | BUY | $1K–$15K | $39.50 | $111.27 2026-08-13 | +181.7% |
| 2016-04-23 | Mike Kelly | BUY | $1K–$15K | $44.08 | $111.27 2026-08-13 | +152.4% |
| 2016-04-19 | Shelley M Capito | BUY | $1K–$15K | $43.85 | $111.27 2026-08-13 | +153.8% |
| 2016-03-31 | William Cassidy | BUY | $1K–$15K | $41.83 | $111.27 2026-08-13 | +166.0% |
| 2016-03-31 | William Cassidy | BUY | $1K–$15K | $41.83 | $111.27 2026-08-13 | +166.0% |
| 2016-01-28 | Virginia Foxx | BUY | $1K–$15K | $36.71 | $111.27 2026-08-13 | +203.1% |
| 2016-01-22 | Virginia Foxx | BUY | $1K–$15K | $40.03 | $111.27 2026-08-13 | +178.0% |
| 2015-09-23 | James B. Renacci | BUY | $1K–$15K | $42.20 | $111.27 2026-08-13 | +163.7% |
| 2015-09-23 | Robert J. Wittman | SELL | $1K–$15K | $42.20 | $111.27 2026-08-13 | -163.7% exit |
| 2015-08-21 | Virginia Foxx | SELL | $15K–$50K | $47.13 | $111.27 2026-08-13 | -0.6% rt |
| 2015-07-30 | Frank A. LoBiondo | BUY | $1K–$15K | $50.77 | $111.27 2026-08-13 | +119.2% |
| 2015-07-28 | Diane Black | BUY | $1K–$15K | $50.94 | $111.27 2026-08-13 | +118.4% |
| 2015-07-21 | Shelley M Capito | BUY | $1K–$15K | $49.76 | $111.27 2026-08-13 | +123.6% |
Return: buys marked to the latest close (open); sells tagged rt are realized round-trips vs a prior disclosed buy; exit = timing (stock move after the sale, seller's perspective).
48 members of the U.S. House and Senate have disclosed Abbott Laboratories transactions under the STOCK Act — 64 purchases and 47 sales. The full member-by-member breakdown, with dates and dollar ranges, is in the table above.
2 members disclosed a ABT purchase in the last 90 days — most recently Gilbert Cisneros on 2026-06-16. See the "Lawmakers who bought ABT recently" section above for the dated list.
Notional-weighted, lawmakers' disclosed ABT buys are up 5.9% versus the latest close of $111.27. Each trade's own return — and realized round-trips on matched sells — is in the Return column.
Yes. Under the 2012 STOCK Act, members of Congress may buy and sell individual stocks but must publicly disclose each transaction within 45 days. Bargo surfaces those filings so you can see who traded ABT and how it performed.